The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Two women reading a guide
Friday 9 November 2018
Today, the National Institute for Health and Care Excellence (NICE) has published some draft guidance about ovarian cancer drug olaparib (Lynparza®). Their current recommendation is that olaparib should not be funded by the NHS, and this is now up for consultation. The National Institute for Health...
News
Mother and daughter go through genetic testing
Monday 22 October 2018
In the news today: the makers of ovarian cancer drug olaparib (Lynparza®) have announced results of a clinical trial showing that the drug is effective in a new group of people - women with ovarian cancer who have a BRCA1 or BRCA2 mutation, who have just completed first-line chemotherapy. Olaparib...
News
Pills on a table
Monday 7 November 2016
Scotland has today made an announcement that puts the nation’s healthcare system ahead of the other UK nations when it comes to ovarian cancer diagnosis, access to drugs and guidelines to treatment. The Scottish Medicines Consortium (SMC) today greenlit new drug olaparib (Lynparza®) for use in the...
News
Thursday 10 December 2015
The National Institute of Health and Care Excellence (NICE) have today announced they have approved olaparib (Lynparza) as a maintenance treatment of relapsed platinum-sensitive ovarian cancer, for women with a BRCA1 or 2 mutation, who have received three or more rounds of platinum based (...

Pages